Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft

Bone Marrow Transplantation

Volumn 24, Issue 4, 1999, Pages 389-396

  Ringden O ^k   Labopin, M ^a   Frassoni, F ^b   Sanz, G F ^c   Demeocq, F ^d   Prentice, H G ^e   Cahn, J Y ^f   Barbui, T ^g   Meloni, G ^h   Schaefer, U W ⁱ   Reiffers, J ^j   Gorin, N C ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b UNIVERSITY OF GENOA   (Italy)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d Pediatric Hôtel Dieu   (France)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^f UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^g Ospedale Civile   (Italy)

^h Biotech Cellular and Haematology   (Italy)

ⁱ UNIVERSITY HOSPITAL ESSEN   (Germany)

^j HAUT LÉVÊQUE HOSPITAL   (France)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Acute leukemia; Allograft; Autograft; Bone marrow transplantation; Relapse

Indexed keywords

ACUTE LEUKEMIA; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; FEMALE; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL;

EID: 0032774458     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701918     Document Type: Article

References (27)

1. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation: parts I and II. New Engl J Med 1975; 292: 832-843, 895-902.
2. Gorin NC, Labopin M, Meloni G et al. Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow-purging by mafosfamide. Leukemia 1991; 5: 896-904.
3. Yeager AM, Kaizer H, Santos GW et al. Autologous bone marrow transplantation in patients with acute non-lymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. New Engl J Med 1986; 315: 141-147.
4. Proctor SJ, Hamilton PJ, Taylor P et al. A comparative study of combination therapy vs marrow transplant in first remission in adult acute lymphoblastic leukaemia. Br J Haematol 1988; 69: 35-39.
5. Weiden PL, Fluornoy N, Thomas ED et al. Anti-leukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. New Engl J Med 1979; 300: 1068-1073.
6. Horowitz MM et al. Graft-versus-leukemia reactions following bone marrow transplantation in humans. Blood 1989; 75: 555-562.
7. Ringdén O et al for the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Bone Marrow Transplant 1996; 18: 921-929.
8. Zittoun R, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New Engl J Med 1995; 332: 217-223.
9. Ringdén O et al for the Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) study. Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Bone Marrow Transplant 1997; 19: 963-968.
10. Weaver CH, Appelbaum FR, Petersen FB et al. Follow-up report on the outcome of patients relapsing after autologous marrow transplantation for malignant lymphoma (letter). J Clin Oncol 1993; 11: 812-813.
11. Storb R et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. New Engl J Med 1986; 314: 729-735.
12. Ringdén O, Horowitz MM, Sondel P et al. Methotrexate, cyclosporine or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood 1993; 81: 1094-1101.
13. Ash RC et al. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T-cell depletion. Bone Marrow Transplant 1991; 7: 443-452.
14. Marmont AM et al. T cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120-2130.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
16. Cox DR. Regression models and life-tables. JR Stat Soc (Series B) 1972; 34: 187-220.
17. Ringdén O, Labopin M, Gorin NC et al. The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft is feasible (Submitted).
18. Beatty PG, Clift RA, Mickelson EM et al. Marrow transplantation from related donors other than HLA-identical siblings. New Engl J Med 1985; 313: 765-771.
19. Ringdén O et al. Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin as compared to monotherapy in recipients of bone marrow from donors other than HLA identical siblings. Bone Marrow Transplant 1992; 9: 19-25.
20. Beatty PG et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991; 51: 443-447.
21. Hows J, Bradley BA, Gore S et al on behalf of the International Marrow Unrelated Search and Transplant (IMUST) study. Prospective evaluation of unrelated donor bone marrow transplantation. Bone Marrow Transplant 1993; 12: 371-380.
22. Marks DI, Cullis JO, Ward KN et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 1993; 119: 207-214.
23. Ringdén O, Remberger M, Persson U et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 1995; 15: 619-625.
24. Barret AJ, Horowitz MM, Gale RP. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 1989; 74: 862-871.
25. Ringdén O, Labopin M, Tura S et al for the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Br J Haematol 1996; 93: 637-645.
26. Hermans J, Suciu S, Stijnen T et al. Treatment of acute myelogenous leukaemia: an EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation. Eur J Oncol 1989; 25: 545-550.
27. Gorin NC, Labopin M, Fouillard L et al. Retrospective evaluation of autologous bone marrow transplantation versus allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1996; 18: 111-117.